Publications by authors named "Syed Asjad Tauheed Zaidi"
Article Synopsis
- - Alzheimer's disease (AD) mainly impacts people aged 65 and older, leading to gradual cognitive and functional decline that disrupts daily activities.
- - The disease is characterized by the presence of amyloid plaques that damage neurons and brain connections, and until 2023, treatments only addressed symptoms without altering the disease's progression.
- - In 2023, the FDA approved Lecanemab and aducanumab, marking the first therapies with the potential to modify the disease, with Lecanemab showing promise in improving cognitive function in patients.
Article Synopsis
- Diabetes mellitus (DM) is a serious condition marked by high blood sugar levels due to insufficient insulin production or poor insulin response, impacting millions globally, particularly those with type 1 diabetes (T1DM), an autoimmune disorder.
- T1DM symptoms include frequent urination, excessive thirst, and weight loss, and it can lead to severe complications like hypoglycemia, diabetic ketoacidosis, and increased risks of heart disease, stroke, kidney issues, vision loss, and neuropathy.
- The article will explore T1DM and various treatments, with a special focus on donislecel, the first FDA-approved cellular therapy for managing this type of diabetes.
Colon carcinoma with brain metastasis is a rare presentation. This presentation is more unusual and unique when the single brain metastatic lesion has two different types of tumors. This rare phenomenon is known as a tumor-to-tumor metastasis.
View Article and Find Full Text PDFSickle cell disease (SCD) is a genetic hereditary blood disease that disrupts normal beta-globin production. Patients with SCD experience a broad range of symptoms ranging from anemia, pain crises, and jaundice to acute coronary syndrome and stroke. SCD has been treated with hydroxyurea since 1998.
View Article and Find Full Text PDFThe aim of this meta-analysis was to assess the effectiveness of acetazolamide as an add-on diuretic therapy in patients with heart failure. This meta-analysis was conducted in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) guidelines. A systematic literature search was independently performed by two authors using MEDLINE, EMBASE, and the Cochrane Database of Systematic Reviews to identify relevant studies assessing the use of acetazolamide in patients with heart failure.
View Article and Find Full Text PDFThis meta-analysis aims to compare high-flow nasal cannula (HFNC) and conventional oxygen therapy (COT) post-extubation in pediatric cardiac surgical patients. The present meta-analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Two authors independently searched three electronic databases including PubMed, Embase, and the Cochrane Library to identify relevant articles published in English from inception to February 2023.
View Article and Find Full Text PDF